Association of electrocardiogram findings with clinical outcomes in patients with chronic coronary syndrome: an analysis of the ISCHEMIA trials.

(up to 6): stable coronary artery disease cardiovascular events electrophysiology myocardial infarction stenosis

Journal

The American journal of medicine
ISSN: 1555-7162
Titre abrégé: Am J Med
Pays: United States
ID NLM: 0267200

Informations de publication

Date de publication:
14 Sep 2024
Historique:
received: 10 05 2024
revised: 30 08 2024
accepted: 08 09 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: aheadofprint

Résumé

We aimed to investigate the association of electrocardiogram (ECG) findings with outcomes in patients with chronic coronary syndrome. This secondary analysis of the ISCHEMIA and ISCHEMIA-CKD trials divided patients with chronic coronary syndrome into two groups, those with a normal ECG tracing and abnormal ECG tracing. Repolarization abnormalities included ST-segment depression ≥0.5mm and T-wave inversion ≥1mm; conduction abnormalities included left and right bundle branch block (LBBB and RBBB). The primary endpoint was cardiovascular death. Outcomes were assessed using a covariate-adjusted Cox-regression model. Of 5876 patients, 2901 (49.4%) had a normal and 2975 (50.6%) an abnormal ECG tracing. An abnormal ECG tracing at baseline, compared with normal ECG, was associated with an increased risk of cardiovascular death (257 of 2975 [8.6%] vs 97 of 2901 [3.3%], adjusted hazard ratio [aHR] 2.01, 95%CI 1.58-2.55) over a median follow-up period of 3.1 years [IQR 2.1-4.2]. This finding was consistent across subgroups except for patients with black skin color and current smokers, in whom an abnormal ECG was not significantly associated with increased risk of cardiovascular death. Individual ECG abnormalities (ST-segment depression [aHR 2.0, 95%CI 1.52-2.63], T-wave inversion [aHR 1.89, 95%CI 1.40-2.54], LBBB [aHR 1.74, 95%CI 1.05-2.90], and RBBB [aHR 1.52, 95%CI 1.04-2.22],) were independently associated with an increased risk of cardiovascular death. In patients with chronic coronary syndrome, an abnormal ECG tracing was associated with an increased risk of cardiovascular death. Our findings underscore the importance of the ECG in cardiovascular risk stratification and prognostication. NCT01471522, BioLINCC ID 14539.

Identifiants

pubmed: 39284482
pii: S0002-9343(24)00572-2
doi: 10.1016/j.amjmed.2024.09.007
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01471522']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest No author reports conflict of interests relevant to this work.

Auteurs

Anselm Jorda (A)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Theresa Pecho (T)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Lisa Christina Horvath (LC)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Ersilio Nishani (E)

Department of Cardiology and Nephrology, Helios Klinikum Berlin-Buch, Berlin, Germany.

Leslie E Bull (LE)

Weill Cornell Medicine, New York, New York, USA.

Felix Bergmann (F)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Christian Nitsche (C)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.

Markus Zeitlinger (M)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Bernd Jilma (B)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Georg Gelbenegger (G)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria. Electronic address: georg.gelbenegger@meduniwien.ac.at.

Classifications MeSH